Homologous versus Heterologous prime-boost COVID-19 Vaccination in autologous hematopoietic stem cell transplantation recipients: a blinded randomized controlled trial

BACKGROUND/PURPOSE: Optimizing vaccine efficacy is of particular concern in patients undergoing hematopoietic stem cell transplantation (HSCT), which mainly have an inadequate immune response to primary SARS-CoV-2 vaccination. This investigation aimed to explore the potential prime-boost COVID-19 va...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharifi Aliabadi, Leyla, Karami, Manoochehr, Barkhordar, Maryam, Hashemi Nazari, Seyed Saeed, Kavousi, Amir, Ahmadvand, Mohammad, Vaezi, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427916/
https://www.ncbi.nlm.nih.gov/pubmed/37593732
http://dx.doi.org/10.3389/fimmu.2023.1237916

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427916/
https://www.ncbi.nlm.nih.gov/pubmed/37593732
http://dx.doi.org/10.3389/fimmu.2023.1237916

Ejemplares similares